☆ 4.7 Letter

Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

CHEST (2021)

Journal

CHEST

Volume 159, Issue 3, Pages 1283-1287

Publisher

ELSEVIER

DOI: 10.1016/j.chest.2020.10.069

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Journal

CHEST

Publisher

ELSEVIER

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial

Journal

CHEST

Publisher

ELSEVIER

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper